![James Bristol](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Bristol
Vorsitzender bei
ERNEXA THERAPEUTICS INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
James A. Bristol is Chairman-Medicinal Chemistry at Gordon Research Conferences.
He is Co-Chairman at Deciphera Pharmaceuticals LLC since 2007.
He is Chairman at Ernexa Therapeutics, Inc. since 2023.
He is Lead Independent Director at Erasca, Inc. since 2018.
He is Director at Protypia, Inc. He is Senior Advisor at Frazier Management LLC since 2009.
Formerly, Dr. Bristol was Independent Director at Ignyta, Inc. from 2014 to 2018.
He was Director at Sudo Biosciences, Inc. from 2021 to 2023.
He was Director at Cadent Therapeutics, Inc. from 2011 to 2021.
He was Independent Director at Deciphera Pharmaceuticals, Inc. from 2023 to 2024.
He was Senior Vice President-Worldwide Discovery Research at Pfizer Inc. from 2003 to 2007.
He was Vice President-Discovery Research at Warner-Lambert Co. in 2000.
He was Executive-in-Residence at Oxford Bioscience Partners.
He was Vice President-Discovery Research at Pfizer (St. Louis) from 2003 to 2007.
He was Member of The Polycystic Kidney Disease Research Foundation.
Education includes an undergraduate degree from Bates College conferred in 1972 and a doctorate from the University of New Hampshire.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC. 0.07% | 15.04.2026 | 207’500 ( 0.07% ) | 3 Mio $ | 31.05.2026 |
| 07.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von James Bristol
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Direktor/Vorstandsmitglied | 01.06.2018 |
| ERNEXA THERAPEUTICS INC. | Vorsitzender | 19.12.2023 |
Protypia, Inc.
 Protypia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides targeted tissue-based protein and peptide mass spectrometry solutions | Direktor/Vorstandsmitglied | - |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Berater | 01.01.2009 |
Gordon Research Conferences
 Gordon Research Conferences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that organizes scientific research conferences and seminars | Corporate Officer/Principal | - |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Vorsitzender | 25.03.2009 |
Ehemalige bekannte Positionen von James Bristol
| Unternehmen | Position | Ende |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Vorsitzender | 03.08.2023 |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Direktor/Vorstandsmitglied | 01.12.2023 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Direktor/Vorstandsmitglied | 01.01.2021 |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von James Bristol
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Bates College
 Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Gordon Research Conferences
Gordon Research Conferences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that organizes scientific research conferences and seminars | Commercial Services |
The Polycystic Kidney Disease Research Foundation
 The Polycystic Kidney Disease Research Foundation Miscellaneous Commercial ServicesCommercial Services The Polycystic Kidney Disease Research Foundation is based in New York, NY. | Commercial Services |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Eterna Therapeutics, Inc.
 Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
Protypia, Inc.
Protypia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides targeted tissue-based protein and peptide mass spectrometry solutions | Commercial Services |
